Full Lancet results for Lilly’s retatrutide show 23.4% weight loss in adults with type 2 diabetes and a BMI of 35 or higher. The drug remains unapproved.
Peer-Reviewed Retatrutide Data Show 23.4% Weight Loss in Adults with Diabetes and BMI of 35 or Higher
by | Oct 2, 2026 | Uncategorized | 0 comments
Recent Comments